Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MAP7D2 | Human | (-)-demecolcine | increases expression | EXP | | 6480464 | Demecolcine results in increased expression of MAP7D2 mRNA | CTD | PMID:23649840 | MAP7D2 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of MAP7D2 mRNA | CTD | PMID:30165855 | MAP7D2 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Map7d2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | MAP7D2 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Map7d2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | MAP7D2 | Human | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Map7d2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | MAP7D2 | Human | 4,4'-sulfonyldiphenol | decreases expression | EXP | | 6480464 | bisphenol S results in decreased expression of MAP7D2 mRNA | CTD | PMID:30616060 | MAP7D2 | Human | Aflatoxin B2 alpha | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of MAP7D2 intron | CTD | PMID:30157460 | MAP7D2 | Human | belinostat | decreases expression | EXP | | 6480464 | belinostat results in decreased expression of MAP7D2 mRNA | CTD | PMID:26272509 | MAP7D2 | Human | belinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP7D2 mRNA | CTD | PMID:27188386 | MAP7D2 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of MAP7D2 intron and Benzo(a)pyrene affects the methylation of MAP7D2 promoter | CTD | PMID:27901495 and PMID:30157460 | MAP7D2 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MAP7D2 mRNA | CTD | PMID:32234424 | MAP7D2 | Human | bisphenol A | affects expression | ISO | Map7d2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of MAP7D2 mRNA | CTD | PMID:25181051 | MAP7D2 | Human | bisphenol A | decreases expression | ISO | Map7d2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of MAP7D2 mRNA | CTD | PMID:32156529 | MAP7D2 | Human | bisphenol A | decreases expression | ISO | Map7d2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of MAP7D2 mRNA | CTD | PMID:30816183 more ... | MAP7D2 | Human | Brodifacoum | decreases expression | ISO | Map7d2 (Rattus norvegicus) | 6480464 | bromfenacoum results in decreased expression of MAP7D2 protein | CTD | PMID:28903499 | MAP7D2 | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of MAP7D2 protein | CTD | PMID:35688186 | MAP7D2 | Human | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of MAP7D2 mRNA | CTD | PMID:21592394 | MAP7D2 | Human | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of MAP7D2 mRNA | CTD | PMID:21592394 | MAP7D2 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of MAP7D2 mRNA | CTD | PMID:27392435 | MAP7D2 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of MAP7D2 mRNA | CTD | PMID:27392435 | MAP7D2 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of MAP7D2 mRNA | CTD | PMID:25562108 | MAP7D2 | Human | diquat | increases expression | ISO | Map7d2 (Mus musculus) | 6480464 | Diquat results in increased expression of MAP7D2 mRNA | CTD | PMID:36851058 | MAP7D2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | MAP7D2 | Human | ethanol | affects splicing | ISO | Map7d2 (Mus musculus) | 6480464 | Ethanol affects the splicing of MAP7D2 mRNA | CTD | PMID:30319688 | MAP7D2 | Human | fenvalerate | increases expression | ISO | Map7d2 (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of MAP7D2 mRNA | CTD | PMID:30307764 | MAP7D2 | Human | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of MAP7D2 mRNA | CTD | PMID:23649840 | MAP7D2 | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of MAP7D2 mRNA | CTD | PMID:27664576 | MAP7D2 | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of MAP7D2 protein | CTD | PMID:37730182 | MAP7D2 | Human | genistein | affects expression | ISO | Map7d2 (Mus musculus) | 6480464 | Genistein affects the expression of MAP7D2 mRNA | CTD | PMID:32186404 | MAP7D2 | Human | hydroquinone | decreases expression | EXP | | 6480464 | hydroquinone results in decreased expression of MAP7D2 mRNA | CTD | PMID:31256213 | MAP7D2 | Human | kojic acid | decreases expression | EXP | | 6480464 | kojic acid results in decreased expression of MAP7D2 mRNA | CTD | PMID:16595896 | MAP7D2 | Human | Licochalcone B | increases expression | EXP | | 6480464 | licochalcone B results in increased expression of MAP7D2 mRNA | CTD | PMID:33647349 | MAP7D2 | Human | manganese(II) chloride | increases methylation | ISO | Map7d2 (Rattus norvegicus) | 6480464 | manganese chloride results in increased methylation of MAP7D2 gene | CTD | PMID:28801915 | MAP7D2 | Human | manganese(II) chloride | decreases expression | ISO | Map7d2 (Rattus norvegicus) | 6480464 | manganese chloride results in decreased expression of MAP7D2 mRNA | CTD | PMID:28801915 | MAP7D2 | Human | N-methyl-4-phenylpyridinium | decreases expression | ISO | Map7d2 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of MAP7D2 mRNA | CTD | PMID:28801915 | MAP7D2 | Human | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP7D2 mRNA | CTD | PMID:27188386 | MAP7D2 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MAP7D2 mRNA | CTD | PMID:26690555 | MAP7D2 | Human | paracetamol | increases expression | ISO | Map7d2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of MAP7D2 mRNA | CTD | PMID:33387578 | MAP7D2 | Human | PCB138 | multiple interactions | ISO | Map7d2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | MAP7D2 | Human | perfluorohexanesulfonic acid | increases expression | ISO | Map7d2 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of MAP7D2 mRNA | CTD | PMID:37995155 | MAP7D2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | MAP7D2 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of MAP7D2 mRNA | CTD | PMID:29301061 | MAP7D2 | Human | Soman | increases expression | ISO | Map7d2 (Rattus norvegicus) | 6480464 | Soman results in increased expression of MAP7D2 mRNA | CTD | PMID:19281266 | MAP7D2 | Human | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of MAP7D2 mRNA | CTD | PMID:21592394 | MAP7D2 | Human | testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of MAP7D2 mRNA | CTD | PMID:21592394 | MAP7D2 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of MAP7D2 mRNA | CTD | PMID:24935251 | MAP7D2 | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of MAP7D2 mRNA | CTD | PMID:24935251 | MAP7D2 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of MAP7D2 mRNA | CTD | PMID:25979313 | MAP7D2 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP7D2 mRNA | CTD | PMID:27188386 | MAP7D2 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of MAP7D2 mRNA | CTD | PMID:23179753 more ... | MAP7D2 | Human | vinclozolin | affects expression | ISO | Map7d2 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of MAP7D2 mRNA | CTD | PMID:19015723 | |